Medical diagnostic product maker Biomerica Inc. emerged as the top biotech stock with the highest jump in new retail ...

Impact of Disease questionnaire (PsAID-12) scores were associated with treatment escalation, physicians primarily relied on clinical assessments when making treatment decisions.

Check the time stamp on this data. Updated AI-Generated Signals for Public Storage (PSA) available here: PSA. Type a few ...

Assessments of serum PSA levels and digital rectal examinations ... placebo-controlled Phase III trial was designed to test the efficacy of daily finasteride treatment at reducing the prevalence ...

Biomerica's Fortel PSA test gains UAE approval for prostate cancer detection. Q2 shows 5% sales growth and reduced losses through cost optimization.

A cancer support group says men's lives are being put at risk because they cannot easily access a key screening test. The ...

PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer- Prostate Cancer: The ...

Discuss PSA testing with Black men from 45, amid disproportionately high rates of late-stage prostate cancer diagnosis, GPs ...

But what has caused such a dramatic rise in Biomerica’s stock price? The answer lies in a groundbreaking development that has taken place in the company’s ongoing mission to revolutionize healthcare ...

Biomerica (BMRA) announced that its Fortel Prostate Specific Antigen Screening Test has received approval from the United Arab Emirates ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

This test, which delivers results in 10 minutes from a simple finger-prick blood sample, is designed to detect early signs of prostate cancer by measuring elevated PSA levels. The approval marks a ...